Evidence map›Paper›PMID 30359437›Full record

ArticlePloS one2018

E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding.

Jennifer Allègre, Jessy Cartier, Valérie Glorian, Nathalie Droin, Baptiste Dumetier, Cémile Kayaci, Jean Berthelet, Simon Gemble, Céline Vuillier, Laurent Maillet and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Jennifer AllègreInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.
Jessy CartierInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.
Valérie GlorianInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.
Nathalie DroinInserm U1170, Gustave Roussy, Villejuif, France.
Baptiste DumetierInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.
Cémile KayaciInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.
Jean BertheletInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.
Simon GembleInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.
Céline VuillierCRCINA, INSERM, U1232, Université de Nantes, Nantes, France.
Laurent MailletCRCINA, INSERM, U1232, Université de Nantes, Nantes, France.
Carmen GarridoInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.
Laurence DubrezInstitut National de la Santé et de la Recherche Médicale (Inserm), LNC UMR1231, Dijon, France.ORCID 0000-0002-7030-2181
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular inhibitor of apoptosis 1 (cIAP1) is an E3-ubiquitin ligase that regulates cell signaling pathways involved in fundamental cellular processes including cell death, cell proliferation, cell differentiation and inflammation. It recruits ubiquitination substrates thanks to the presence of three baculoviral IAP repeat (BIR) domains at its N-terminal extremity. We previously demonstrated that cIAP1 promoted the ubiquitination of the E2 factor 1 (E2F1) transcription factor. Moreover, we showed that cIAP1 was required for E2F1 stabilization during the S phase of cell cycle and in response to DNA damage. Here, we report that E2F1 binds within the cIAP1 BIR3 domain. The BIR3 contains a surface hydrophobic groove that specifically anchors a conserved IAP binding motif (IBM) found in a number of intracellular proteins including Smac. The Smac N-7 peptide that includes the IBM, as well as a Smac mimetic, competed with E2F1 for interaction with cIAP1 demonstrating the importance of the BIR surface hydrophobic groove. We demonstrated that the first alpha-helix of BIR3 was required for E2F1 binding, as well as for the binding of Smac and Smac mimetics. Overexpression of cIAP1 modified the ubiquitination profile of E2F1, increasing the ratio of E2F1 conjugated with K11- and K63-linked ubiquitin chains, and decreasing the proportion of E2F1 modified by K48-linked ubiquitin chains. ChIP-seq analysis demonstrated that cIAP1 was required for the recruitment of E2F1 onto chromatin. Lastly, we identified an E2F-binding site on the cIAP1-encoding birc2 gene promoter, suggesting a retro-control regulation loop.

Indexed as

Binding SitesCell CommunicationCell LineChromatinE2F1 Transcription FactorHeLa CellsHumansInhibitor of Apoptosis ProteinsProtein BindingProtein DomainsSignal TransductionUbiquitinationChromatinE2F1 Transcription FactorInhibitor of Apoptosis Proteins

Identifiers

PMID30359437
PMCPMC6201919
OpenAlexW2898343493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.